ELV
Elevance Health Inc
Elevance Health Inc historical holders
total: 16
Baupost Group Elevance Health Inc transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 3
- Reduced:
- 1
- Held since:
- 2025 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
Seth Klarman has been an institutional investor in Elevance Health Inc (ELV) since 2025 Q1. According to 2026 Q1 report, Seth Klarman holds 1,275,154 shares with a market value of roughly $373.30M representing 7.30% of their equity portfolio. The fund/company first acquired ELV in 2025 Q1, initially purchasing 246,000 shares. Since the initial investment, Baupost Group has made 4 more transactions in this position.
Does Seth Klarman still hold ELV?
Yes, Seth Klarman continues to hold Elevance Health Inc (ELV). According to their 2026 Q1 report, they maintain a position of 1,275,154 shares valued at approximately $373.30M, representing 7.30% of their equity portfolio.
When did Seth Klarman first invest in ELV?
Seth Klarman first invested in Elevance Health Inc (ELV) in 2025 Q1 at the reported quarter-end price of $434.96 per share, acquiring 246,000 shares in their initial purchase.
What is Seth Klarman's average cost basis for ELV?
Based on historical transaction data, Seth Klarman's estimated cost basis for Elevance Health Inc (ELV) is approximately $362.14 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $362.14
- Weighted AVG sell price:
- $350.55
ELV transactions history by Baupost Group
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
7.30%
|
1,275,154
|
$292.75
|
$373,301,000
|
+0.46% (+5,852)
|
+0.03%
|
|
2025 Q4
|
8.43%
|
1,269,302
|
$350.55
|
$444,954,000
|
-3.77% (-49,698)
|
-0.36%
|
|
2025 Q3
|
8.90%
|
1,319,000
|
$323.12
|
$426,195,000
|
+114.12% (+703,000)
|
+4.74%
|
|
2025 Q2
|
5.80%
|
616,000
|
$388.96
|
$239,599,000
|
+150.41% (+370,000)
|
+3.48%
|
|
2025 Q1
|
3.06%
|
246,000
|
$434.96
|
$107,000,000
|
new
|
+3.06%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.